<DOC>
	<DOCNO>NCT02410902</DOCNO>
	<brief_summary>The purpose study determine whether CM-AT safe effective treat core symptom autism child level fecal chymotrypsin .</brief_summary>
	<brief_title>A Trial CM-AT Children With Autism With All Levels FCT ( The Blum Study )</brief_title>
	<detailed_description>Autism clearly significant cause disability pediatric population . Many child Autism exhibit impaired protein digestion may may manifest self-restricted diet . The inability digest protein affect availability essential amino acid body . CM-AT design enhance protein digestion thereby potentially restore pool essential amino acid . Essential amino acid play critical role expression several gene important neurological function serve precursor key neurotransmitter serotonin dopamine . CM-AT proprietary enzyme design granulate powder take three time daily .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<criteria>Meets current Diagnostic Statistical Manual Mental Disorders ( DSMIVTR ) Autism ( Autistic Disorder ) , screen SCQ confirm ADIR ; Patient weigh &lt; 13kg ( 28.6 lb ) Previous allergy porcine ( pork ) product Previous history severe head trauma stroke , loss consciousness , seizure ( need seizure medication either present past ) within one year enter study uncontrolled systemic disease Diagnosis : HIV , cerebral palsy , endocrine disorder , pancreatic disease , muscular dystrophy , know genetic disorder , blood dyscrasia , ongoing GI disease Evidence severe , moderate uncontrolled systemic disease ; and/or comorbid condition Investigator 's Medical Director 's opinion make undesirable subject participate study jeopardize compliance protocol ; Within 30 day start study , certain supplementation , chelation dietary restriction ( 30 day washout period would require inclusion ) ; Ongoing dietary restriction allergy reason except nut allergy ( lactosefree allowable ) ; Use stimulant medication must discontinue 5 day prior enter study . Subject must stable dose SSRI 's least 30 day . Inability ingest study drug and/or follow prescribe dose schedule</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Autism</keyword>
</DOC>